Evaluating the relationship between the radial pulse wave and gynecological disease

ISRCTN ISRCTN20480882
DOI https://doi.org/10.1186/ISRCTN20480882
Secondary identifying numbers TCHIRB-10703121-E
Submission date
19/05/2020
Registration date
25/05/2020
Last edited
24/06/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Harmonic analysis has been proven to be used to assess circulation status. In this study, we will observe the correlation between various common gynecological diseases and harmonic indicators through harmonic analysis. It is expected that harmonic indicators may become risk indicators for common gynecological diseases.

Who can participate?
Adults aged 20 and older with gynecological diseases.

What does the study involve?
Participants are provided with information sheets and obtain written informed consent. Information on lifestyle questionnaires and medical history are updated in each follow-up visit. Participants are then invited to a clinic room for radial pressure wave measurement.

What are the possible benefits and risks of participating?
Doctors take the radial pulse spectrum as risk variables based on the study and previous research. The patients may benefit from early detection of gynecological diseases in the future. The radial pulse measuring device is non-invasive.

Where is the study run from?
Taipei City Hospital (Taiwan)

When is the study starting and how long is it expected to run for?
April 2018 to March 2022

Who is funding the study?
Taipei City Hospital (Taiwan)

Who is the main contact?
1. Dr Chih-Yu Chen (Public), tpech.anthony@m2k.com.tw
2. Dr Sheng-Hung Wang (Scientific), rax.wang@miiann.com

Contact information

Dr Chih-Yu Chen
Public

No.10, Sec. 4
Ren’ai Rd.
Da’an Dist
Taipei City
106
Taiwan

Phone +886 227093600
Email tpech.anthony@m2k.com.tw
Dr Sheng-Hung Wang
Scientific

26F-1
No. 161
Songde Rd.
Taipei
11085
Taiwan

Phone +886 223463003
Email rax.wang@miiann.com

Study information

Study designNon-invasive observational study
Primary study designObservational
Secondary study designLongitudinal study
Study setting(s)Hospital
Study typeScreening
Participant information sheet No participant information sheet available
Scientific titleA study on gynecological disease classification by harmonic analysis of pressure pulse waveform
Study objectivesHarmonic analysis has been proven to be used to assess circulation status. In this study, we will observe the correlation between various common gynecological diseases and harmonic indicators through harmonic analysis. It is expected that harmonic indicators may become risk indicators for common gynecological diseases.
Ethics approval(s)Approved 20/04/2018, Institutional Review Board of Taipei City Hospital (8F., No. 10, Sec. 4, Ren’ai Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C.); +886 227093600; no email provided), ref: TCHIRB-10703121-E. Extension granted 08/04/2019.
Health condition(s) or problem(s) studiedRisk factors in gynecological diseases
InterventionAll subjects underwent radial pressure wave measurement. Spectrum analysis of radial pressure wave was calculated and transformed into Fourier series coefficients Cn and Pn.

The enrolled group is investigated from April 2018. Both oral and written information about the study is given to the subjects. Informed consent is obtained from subjects after receiving approval from the institutional review board of Taipei City Hospital. The enrolled patients receive radial pulse wave measurement while referral until the end of the study or quit the project.

The study consists of two clinical tests:
1. The cross-sectional part measures the radial blood pressure wave when a person first joined this study. The radial pulse spectrum index is derived from the measurement. The measurement is noninvasive. The interactions among the various common gynecological diseases and the risk factors (including the radial pulse spectrum index) are evaluated. The medical records of subjects including the blood test, urine examination, medication history, and lifestyle questionnaires to investigate the risk confounded such as age, gender, body mass index, blood pressure, low-density cholesterol, high-density cholesterol, and smoke history are analysed.
2. The longitudinal part: This part takes the risk evaluation of cross-sectional cohort study as the baseline. We continue to measure the radial pulse spectrum and record the new-onset gynecological diseases at 4-year intervals.

In both parts of the cross-sectional and longitudinal part, it builds up the clinical risk variables for patients with gynecological diseases. Those clinical variables are safe enough to facilitate in routine clinical practice and also are cost-effective to repeat within months. Thus, periodic screening for those risk factors may help the doctors to evaluate the conditions of patients with gynecological diseases.
Intervention typeOther
Primary outcome measure1. Radial blood pressure wave is assessed using a miniature pressure transducer (TD01C, Taiwan) at time of enrollment
2. Hormones (such as E2, LH, FSH and Prolactin) are assessed using blood test at time of enrollment
3. CA-125 and AFP are assessed using blood test at time of enrollment
Secondary outcome measuresPhysician diagnosis from the medical record at time of enrollment.
Overall study start date01/04/2018
Completion date31/03/2022

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants1,500
Total final enrolment825
Key inclusion criteria1. Patients with gynecological diseases
2. Over 20 years old
Key exclusion criteriaSevere diseases or acute symptoms are excluded if the pressure wave measurement could not be performed
Date of first enrolment08/05/2018
Date of final enrolment31/03/2022

Locations

Countries of recruitment

  • Taiwan

Study participating centre

Taipei City Hospital
Department of Obstetrics and Gynecology
Renai Branch
Taipei
106
Taiwan

Sponsor information

Taipei City Hospital
Hospital/treatment centre

No.10, Sec. 4
Ren’ai Rd.
Da’an Dist.
Taipei City
106
Taiwan

Phone +886 227093600
Email tpech.anthony@m2k.com.tw
Website http://english.tch.gov.taipei/
ROR logo "ROR" https://ror.org/02gzfb532

Funders

Funder type

Hospital/treatment centre

Taipei City Hospital

No information available

Results and Publications

Intention to publish date31/03/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results 16/10/2019 13/09/2022 No No
Abstract results 16/10/2019 13/09/2022 No No
Abstract results 16/10/2019 13/09/2022 No No
Abstract results 11/11/2019 13/09/2022 No No
Results article 01/09/2021 13/09/2022 Yes No
Results article 29/10/2021 13/09/2022 Yes No
Protocol file 14/09/2022 No No
Dataset 24/06/2024 No No

Additional files

ISRCTN20480882_PROTOCOL.pdf

Editorial Notes

24/06/2024: Link to dataset added.
14/09/2022: Uploaded protocol (not peer reviewed). Total final enrolment added.
13/09/2022: Publication references added.
22/05/2020: Trial’s existence confirmed by Institutional Review Board of Taipei City Hospital.